· 
Life Insurance with Brain Cancer or Tumour in Canada
A brain tumour does not automatically mean uninsurable. Some benign, stable, well-documented cases may qualify for fully underwritten coverage when the file is routed carefully.
By Parvesh Benning, Licensed Life Insurance Broker
Updated: May 28, 2026
A brain cancer or brain tumour diagnosis closes fewer doors than most people assume. What changes is the routing. The type of tumour, the WHO grade, time since treatment, and what shows up on follow-ups determine which Canadian carrier sees the file and what the offer looks like when it comes back.
Life Insurance with Brain Cancer or Tumour in Canada
By Parvesh Benning, Licensed Life Insurance Broker
Updated: May 28, 2026
A brain cancer or brain tumour diagnosis closes fewer doors than most people assume. What changes is the routing. The type of tumour, the WHO grade, time since treatment, and what shows up on follow-ups determine which Canadian carrier sees the file and what the offer looks like when it comes back.
Most people who land on this page have already been told, or have already assumed, that a brain tumour history makes them uninsurable in Canada. That is often not the actual answer.
The harder question is which product, which carrier, and on what timeline. A benign meningioma fully removed eight years ago routes differently from a glioblastoma diagnosed last year, which routes differently from an incidentally found small pituitary adenoma being monitored without surgery. Different files, different conversations, all of them with options.
This guide walks through how Canadian carriers actually treat brain tumour files, what the WHO grading system means for life insurance underwriting, how critical illness coverage differs from life insurance for these cases, and how to apply. Carrier underwriting references are pulled from current guidelines, not from marketing material.
What this guide covers
- Can you get life insurance with brain cancer or a brain tumour?
- Benign vs malignant: the single biggest variable
- How insurers grade brain tumours (WHO grades 1 to 4)
- How a brain tumour file gets routed in practice
- Critical illness coverage for brain tumours
- What insurers ask for
- How long to wait after treatment
- Coverage options after a brain tumour diagnosis
- What a rated life insurance offer actually costs
- How to apply after a brain tumour diagnosis
- Frequently asked questions
Can You Get Life Insurance with Brain Cancer or a Brain Tumour in Canada?
Yes. A brain tumour does not mean automatically uninsurable. I have placed clients with brain tumour histories across the full coverage spectrum: fully underwritten policies, simplified-issue, and guaranteed-issue. The route depends on the tumour, the timeline, and what else is on the file.
The reason the public-facing answer is often “no” is that most consumer comparison sites lump every brain tumour into one bucket. The actual underwriting reality is far more granular than that.
A
Benign, fully removed, stable for years
Fully underwritten policies are realistic. Term life, whole life, universal life all in play. I have placed multiple clients in this category at fully underwritten rates without ratings. The carrier shortlist depends on tumour type, location, and follow-up history.
B
Benign, under active surveillance (no surgery yet)
Small incidental findings being watched, not treated. This is its own underwriting conversation. Some carriers will rate the file, some will postpone until a stability window closes, some will look at it favourably if scans are stable and the tumour is below thresholds. Preliminary assessment is the only way to know which carrier reads it which way.
C
Malignant, post-treatment, inside the early stability window
Simplified-issue is usually the realistic path here. Five to ten health questions on the application, no medical exam, decision within days to a couple of weeks. Coverage caps vary by tier and time since treatment.
D
In active treatment, or recently diagnosed
Guaranteed-issue is often the realistic route. No medical questions, no exam. Coverage typically caps around $50,000 with a two-year waiting period on natural-cause death. I have placed clients in exactly this scenario, including a recent case where we put a Manulife guaranteed policy in force during a brain tumour situation. That coverage is still in place today.
The single biggest mistake I see is assuming the answer is “no” based on a search result or one carrier’s blanket response. Many brain tumour files still have at least one route worth reviewing. The work is figuring out which product, which carrier, and what terms may be realistic.
For the broader picture across all cancer types and the general framework that sits underneath, see our guide to life insurance after cancer in Canada.
Benign vs Malignant: The Single Biggest Variable
The first question on any brain tumour file is benign or malignant. Two diagnoses with the same name on the front of a medical record, completely different underwriting conversations behind it. Most consumer guides treat these the same. Underwriters do not.
Roughly two-thirds of brain tumours diagnosed in Canada are benign. The most common types (meningioma, vestibular schwannoma, pituitary adenoma) grow slowly, stay localized, and do not spread to other organs. Many are found incidentally on a scan done for an unrelated reason. Malignant brain tumours (glioblastoma, anaplastic astrocytoma, medulloblastoma) are aggressive, invade surrounding tissue, and carry recurrence risk even after treatment.
| Factor | Benign | Malignant |
|---|---|---|
| Growth pattern | Slow, defined edges, contained | Aggressive, invasive, spreads locally |
| Recurrence risk | Low after full removal, type-dependent | Moderate to high, varies by grade |
| Common examples | Meningioma, vestibular schwannoma, pituitary adenoma, craniopharyngioma | Glioblastoma, anaplastic astrocytoma, oligodendroglioma, medulloblastoma |
| Typical LI underwriting | Fully underwritten possible, standard rates realistic at most carriers once stable | Rated, postponed, or simplified-issue route, depending on grade and stability window |
| Post-treatment monitoring | Periodic MRI, often 1-2 year intervals after stability | Frequent MRI, oncology follow-up, often life-long |
Primary vs metastatic is a separate split. Primary brain tumours start in the brain itself. Metastatic (secondary) brain tumours originate as cancer elsewhere (lung, breast, colon are the most common origins) and spread to the brain. Metastatic brain cancer underwrites very differently from primary brain cancer because the underlying original cancer also affects the file. A metastatic file is essentially two files:
How Insurers Grade Brain Tumours (WHO Grades 1 to 4)
The World Health Organization classifies brain tumours on a 1 to 4 scale based on how the tumour cells look under a microscope and how aggressively they behave. Canadian life insurance underwriters use this grading system directly when reading a pathology report. Grade is one of the first details an underwriter looks for, alongside tumour type and time since treatment.
This section is sourced from current WHO classification standards (last major revision 2021) and is provided for educational reference. The grade alone never decides an underwriting outcome. It sits alongside tumour type, location, treatment, and follow-up history.
Grade 1
Benign, slow-growing
Slow-growing, well-defined edges, low recurrence risk after complete removal. Often considered curable with surgery alone. Common examples: pilocytic astrocytoma, meningioma (most), craniopharyngioma.
Typical LI outcome: Fully underwritten coverage realistic once stability is established. Standard rates possible at many Canadian carriers after a defined time window post-surgery.
Grade 2
Low-grade, slower recurrence risk
Still relatively slow-growing but more likely to recur than Grade 1. Some Grade 2 tumours can progress to higher grades over years. Common examples: diffuse astrocytoma, oligodendroglioma, atypical meningioma.
Typical LI outcome: Fully underwritten coverage possible, often with a temporary rating (table rating or flat extra) that decreases over time. Simplified-issue is an alternative path inside the early stability window.
Grade 3
Malignant, actively growing
Cancerous, actively growing and invading surrounding tissue. Treatment typically combines surgery, radiation, and chemotherapy. Common examples: anaplastic astrocytoma, anaplastic oligodendroglioma.
Typical LI outcome: Longer postpone windows at fully underwritten carriers, often five years or more. Simplified-issue and guaranteed-issue are usually the working paths during the postpone period.
Grade 4
Highly malignant, aggressive
Most aggressive form, fast-growing, invasive, high recurrence risk. Treatment is often palliative or aimed at extending stable disease. Common examples: glioblastoma multiforme (GBM), medulloblastoma in some classifications.
Typical LI outcome: Fully underwritten coverage is generally not available. Guaranteed-issue is the realistic path, with coverage caps around $50,000 and a two-year waiting period on natural-cause death.
One detail worth knowing: WHO grade is set at the time of the original diagnosis based on the pathology report. It does not change over time, even if the patient remains stable for years. A Grade 2 tumour treated successfully ten years ago is still classified as Grade 2 on the underwriting file. What changes is the stability window and the recurrence picture, not the grade.
This is also why a “benign” tumour and a “Grade 1” tumour are not synonyms. Grade 1 tumours are usually benign. Some benign tumours, like atypical meningiomas, sit at Grade 2. The pathology report gives both the histological type and the WHO grade. Underwriters read both.
How a Brain Tumour File Gets Routed in Practice
A brain tumour file gets routed by pulling the current carrier underwriting guidelines and running a preliminary assessment. I am not a brain specialist. No experienced broker should claim to be. What an experienced broker does is read the pathology report, match the file to the published carrier guides, and confirm the indicative decision with the underwriting desk before any formal application gets submitted.
That last step is what protects the file. Every formal application leaves a record with the Medical Information Bureau, the industry-shared underwriting database. A postpone or decline at one carrier becomes visible to the next carrier the file gets sent to. Blind submissions to multiple companies are one of the most common ways brain tumour files get harder than they needed to be.
A real placement from my files
“Brain tumour situation. We were able to put a guaranteed policy in place with Manulife. Two-year waiting period on it, but the coverage went in force. That policy is still in place today.”
The coverage was modest by design. It existed in a window where fully underwritten was off the table. The point was insurability in place, not maximum face amount.
That case worked because the route matched the moment. Guaranteed-issue at the right carrier, accepting the trade-off (lower face, two-year waiting period on natural-cause death) in exchange for coverage that actually issued. The alternative would have been chasing fully underwritten options that were going to come back postponed or declined, leaving the client with no coverage and a marked-up MIB record.
The working sequence on every brain tumour file looks roughly like this:
- 1
Pull the pathology report. Histological type, WHO grade, tumour location, size, completeness of resection. Most fully underwritten Canadian carriers will not issue a final offer without this.
- 2
Match to carrier underwriting guides. Different carriers weigh tumour type and grade differently. The current guides narrow the shortlist to two or three carriers most likely to issue on these specific facts.
- 3
Run an anonymous preliminary assessment. Email the underwriting desk with the medical specifics, no name attached. Underwriter replies with an indicative decision (likely rating, likely postpone, or likely decline) on those facts. No formal application has been filed.
- 4
Run simplified-issue paths in parallel. If the fully underwritten window looks tight, line up the simplified-issue alternative at the same time. The application questions and tier limits tell us whether the file qualifies before any submission.
- 5
Submit the formal application to one carrier. The carrier with the best probable offer based on the preliminary assessment. Never blind-submit to multiple.
- 6
Re-place when timing opens up. If the first policy was guaranteed-issue or simplified-issue, watch for the moment fully underwritten becomes available. The first policy stays in force until the second one issues.
Most brain tumour files I review tend to fall into one of three outcomes: a fully underwritten policy with no rating, a fully underwritten policy with a temporary rating that decreases over years, or a simplified-issue or guaranteed-issue policy that bridges the early window. Many files still have a route. The work is figuring out which.
For the comparative picture across cancer carriers, see our carrier comparison for cancer cases in Canada.
Critical Illness Coverage for Brain Tumours (and Why It’s Different from Life Insurance)
Life insurance, critical illness insurance, and disability insurance all sound similar but do completely different things. Anyone searching brain tumour coverage in Canada needs to know which product they actually need before reading further, because the wrong product produces the wrong answer.
Life Insurance
Pays a lump-sum death benefit to the beneficiary when the insured passes. Pays nothing while the insured is alive (with the rare exception of an accelerated death benefit on terminal cases). The product covered on this page.
Critical Illness
Pays a tax-free lump sum (often $25,000 to $2 million) on the diagnosis of a covered condition, while the insured is alive. Each policy defines exactly which conditions are covered and under what circumstances. The definitions matter more than the marketing.
Disability
Replaces a portion of income if the insured cannot work due to illness or injury. Every disability policy is different. Payouts, definitions, exclusions, and elimination periods all depend on the specific contract. Disability claims for brain tumours hinge entirely on the wording of the individual policy.
The most common confusion on this page is around critical illness. People assume “brain tumour” on a CI policy means automatic payout on diagnosis. That is not how the contracts read. CI definitions are narrow, technical, and full of exclusions most consumers never see until they file a claim.
Here is a representative example from a current Canadian carrier (Industrial Alliance) showing how Benign Brain Tumour is actually defined for critical illness purposes:
Industrial Alliance critical illness policy: Benign Brain Tumour definition
Definition: A definite diagnosis of a non-malignant tumour located in the cranial vault and limited to the brain, meninges, cranial nerves, or pituitary gland. The tumour must require surgical or radiation treatment or cause irreversible objective neurological deficit(s). Diagnosis must be made by a Specialist.
90-day exclusion: No benefit is payable if, within the first 90 days following policy effective date or last reinstatement, the insured has any signs, symptoms, or investigations leading to a benign brain tumour diagnosis (covered or excluded under the policy), regardless of when the actual diagnosis is made.
6-month reporting requirement: Medical information about the diagnosis and any signs, symptoms, or investigations leading to it must be reported to the insurer within 6 months of the diagnosis date, or the insurer reserves the right to deny the claim and any related future critical illness claims.
Specific exclusion: No benefit is payable for pituitary adenomas less than 10 mm.
Reading that definition closely is what reveals the underwriting reality. A small meningioma found incidentally on a scan, being watched, no surgery and no symptoms, does not trigger this benefit. Neither does a pituitary adenoma under 10 mm. The CI contract is designed to pay only when the tumour has produced real medical action (surgery, radiation) or real neurological consequence.
Definitions and exclusions vary across Canadian carriers. The IA wording above is one example. Other carriers may use different size thresholds, different exclusion windows, or different reporting requirements. Always verify the specific policy language before assuming what is covered.
If you are searching for a disability claim answer
Many people land here from queries about benign brain tumour disability insurance claims or claim denials. That is a different product entirely from what this page covers. Disability outcomes depend on the specific wording of the individual disability policy: what counts as “totally disabled,” what occupation definition applies, what exclusions are written into the contract, and how the carrier interprets the medical evidence.
A licensed broker who has the actual policy in hand is the only person who can give a useful answer on disability claims. Generic guides online cannot substitute for reading the contract.
The practical takeaway: critical illness and life insurance are best put in place before any brain tumour diagnosis, while the file is clean. Once a diagnosis is on the record, CI coverage on that specific condition becomes excluded or postponed at most carriers, and life insurance routing changes as this page describes. The window to put both products in place is before the medical event, not after.
What Insurers Ask For
The pathology report is usually the single most important document on a brain tumour life insurance file. Without it, most fully underwritten Canadian carriers will not issue a final offer. Everything else on the file (treatment dates, imaging, follow-up records) sits in support of what the pathology report says.
The documentation list below covers what an experienced broker pulls together before submitting any formal application. Most of this can be requested directly from the neurosurgeon, oncologist, or family doctor. Having it in hand before the application starts saves weeks on the file.
Pathology report
Critical
From the biopsy or surgical pathology. Confirms histological type, WHO grade, tumour size, completeness of resection, and (where relevant) molecular markers. If you don’t have a copy, request one from your neurosurgeon or oncologist’s office.
Imaging history
High importance
Pre-treatment MRI or CT, post-treatment imaging, and the most recent follow-up scan. Active surveillance cases (tumour being monitored without surgery) need the full imaging timeline showing stability or growth over time.
Treatment dates and protocol
High importance
Dates of any craniotomy, debulking, or biopsy. Start and end dates of any radiation cycles (including gamma knife or cyberknife). Start and end dates of any chemotherapy. The treatment-complete date sets the clock for most carrier timing rules.
Neurological symptom history
High importance
Pre-diagnosis symptoms (headaches, seizures, vision changes, balance issues), symptoms during treatment, and any residual deficits since. Residual deficits matter for both LI and CI underwriting, and may also affect driving license status with provincial authorities.
Follow-up history
High importance
Dates of follow-up visits with the neurosurgeon, neuro-oncologist, or family doctor since treatment ended. Insurers want to see active surveillance, not gaps. A clean recent follow-up is worth more on the file than five years of no-news.
Current medications
Standard
Complete current prescription list, including anti-seizure medications, steroids tapered after treatment, hormone replacement (relevant for pituitary cases), and anything else ongoing.
Family history and other conditions
Standard
Family history of cancer (which type, which relative, at what age). Other medical conditions on the file (diabetes, cardiac history, smoking status). Brain tumour files do not exist in isolation, and stacked conditions tighten the carrier shortlist.
The genetic test protection note that applies to other cancers also applies here. Under the federal Genetic Non-Discrimination Act, Canadian insurers cannot ask about or use genetic test results in underwriting any individual life insurance or critical illness application. Applicants are not required to disclose genetic testing or genetic test results. Family medical history itself is a fair underwriting input, but tested-for-a-marker is not.
One practical tip: many specialists’ offices charge a small fee (typically $30 to $100) to produce a copy of the pathology report and recent imaging reports. The fee is worth paying upfront. It is far cheaper than spending weeks waiting on the insurer to chase the records.
How Long to Wait After Treatment
The right answer is almost always to apply for what is available now, then re-place later when better terms open up. The premium on the first policy is locked in at the age you applied, not the age you eventually qualified for fully underwritten coverage. Waiting five years to get a “better” policy can mean paying more for the eventual one because of the age gap.
What is “available now” depends on the type of tumour, the grade, and how recently treatment ended. The general timeline below describes typical patterns. Individual cases vary widely, especially across benign vs malignant.
During treatment, or recently diagnosed
Months 0 to 6 post-diagnosis
Fully underwritten coverage is generally off the table during active treatment. Guaranteed-issue is the realistic path, with coverage caps around $50,000 and a two-year waiting period on natural-cause death. Premiums refunded (sometimes with interest) if the insured passes inside the waiting window. The point during this stage is insurability in place, not maximum face amount.
Treatment ended, inside the early stability window
6 months to 2 years post-treatment
Simplified-issue paths start opening up depending on the carrier and tumour type. Benign Grade 1 cases fully removed may even qualify for fully underwritten coverage with a rating at some carriers in the later end of this window. Malignant cases usually remain in simplified-issue or guaranteed-issue territory.
The transition window
2 to 5 years post-treatment
Fully underwritten coverage opens at most Canadian carriers for benign cases with clean follow-ups. Standard rates are realistic for Grade 1 meningiomas, pituitary adenomas under threshold, and vestibular schwannomas. Low-grade glioma files (Grade 2) usually carry a temporary rating during this window. High-grade malignant files often still need more time at fully underwritten carriers but have multiple simplified-issue options available.
Past the five-year mark with clean follow-ups
5 to 10 years post-treatment
Most fully underwritten Canadian carriers will look at the file favourably. Benign cases that were Grade 1, fully resected, and have clean MRI surveillance often hit standard rates. Grade 2 and Grade 3 files usually carry a permanent or decreasing rating in this window, depending on the carrier. Glioblastoma and other Grade 4 files generally still route to guaranteed-issue at this stage.
Ten or more years stable, with no recurrence
10+ years post-treatment
Many fully underwritten Canadian carriers treat the applicant similarly to someone with no major medical history, provided other risk factors are not present (smoking, diabetes, cardiac history). Standard market rates are realistic for benign cases and for low-grade malignant cases that have remained stable. Re-placement of an older rated policy into a new policy without the rating is worth running on every file that crosses this threshold.
The mistake to avoid
Waiting five years for the “perfect” fully underwritten policy when guaranteed-issue or simplified-issue is available right now. Five years without coverage is five years of risk on the family, and the eventual policy is priced at the older age at application. The sequence that works is: place what you can now, watch for the moment better terms open up, then re-place. The first policy stays in force until the second one issues, so coverage is never broken during the transition.
One detail that matters across all five windows above: the timeline restarts if there is a recurrence or a new finding. A meningioma client who has been stable for seven years and then has a recurrence is back to the early-window conversation. This is one reason annual review of an existing policy makes sense for brain tumour cases, especially for files placed at simplified-issue or guaranteed-issue while waiting for fully underwritten options to open.
Coverage Options After a Brain Tumour Diagnosis
Four product types cover the realistic options for brain tumour survivors in Canada: fully underwritten life insurance, simplified-issue, guaranteed-issue, and group life insurance through an employer. Each fits a different point on the post-diagnosis timeline. Most brain tumour files end up using two of these in sequence rather than one alone.
| Product | Coverage cap | Issue speed | Best fit when |
|---|---|---|---|
| Fully underwritten | Up to $10 million | 4 to 8 weeks | Past the initial postpone window, stable follow-ups, need exceeds simplified-issue caps. Lowest cost per $1,000 of coverage once the rating settles. |
| Simplified-issue | Up to $750,000 | 48 hours to 2 weeks | Inside the fully underwritten postpone window, but want more than guaranteed-issue offers. Tier depends on time since treatment and tumour type. |
| Guaranteed-issue | Up to $50,000 (some $100,000) | Days | Active treatment, recent diagnosis, or where simplified-issue is not yet available. Two-year waiting period on natural-cause death. Coverage in force within days. |
| Group (employer) | 1x to 2x salary baseline | Immediate (enrolment) | Access to employer benefits, has not yet enrolled, or has not maxed the no-evidence amount. Useful supplement, not a replacement for personally owned coverage. |
Group life insurance deserves a closer look on brain tumour files, because the underwriting on the no-evidence baseline does not consider individual medical history at all. If the applicant has access to employer group benefits and has not yet enrolled, or has not yet maxed the no-evidence amount, that is coverage available immediately regardless of any brain tumour diagnosis. The trade-off is portability. Group coverage ends when employment ends, and the conversion option that follows is usually expensive and limited.
The two-product sequence that works on most files
Place guaranteed-issue or simplified-issue coverage now to lock in insurability during the most exposed window. The face amount is modest by design. The point is that coverage exists.
Two to five years later, when the fully underwritten window opens at one or more Canadian carriers, run the file again. New application, new carrier, potentially no rating or a much smaller one. The first policy stays in force until the second one issues. The survivor is never without coverage during the transition.
The product the survivor needs the most is usually not the most expensive one. A $50,000 guaranteed-issue policy that issues immediately is worth more on the file than a $1 million fully underwritten policy that will not issue for another four years. Insurability in place now, optimized terms later, is the sequence most brain tumour files actually run on. For the broader product mechanics, no-medical life insurance in Canada covers the simplified-issue and guaranteed-issue distinctions in more detail.
What a Rated Life Insurance Offer Actually Costs
A rating raises the premium by a set multiple. On a $250,000 20-year term policy for a male age 55, non-smoker, that means moving from roughly $120 a month at standard rates to roughly $178 or $236, depending on how the file gets rated.
“Rated” means the insurer issued the policy but priced it above standard because of something on the medical file. Carriers write it two ways and both mean the same thing. A “+50” offer and a “150%” offer are identical: one and a half times the standard premium. A “+100” or “200%” offer means double.
Standard
$120
No rating. What a clean file pays.
+50, or 150%
$178
One and a half times standard.
+100, or 200%
$236
Double standard. Still a policy in force.
Male, age 55, non-smoker, $250,000, 20-year term, monthly. The two rated figures are worked examples, not quotes. Nobody with a similar history should assume the same rating. Based on current carrier rates, illustrative only, subject to underwriting and change.
One detail that trips people up. The policy fee is not rated. It gets stripped out before the multiple is applied, then added back after. Multiplying the whole premium including the fee overstates the cost, and the error grows as the rating climbs. If you want to see how standard pricing moves by age and term before any rating enters the picture, our term life insurance quotes page lays it out.
When fully underwritten is off the table
Guaranteed issue is a last resort, not a first answer. First we want to see whether there is a viable underwritten solution. When there is not, the numbers are at least known: Manulife Guaranteed Issue Life at $50,000 for a male age 55 runs about $152 a month, level premiums, no health questions asked.
That price carries a two-year exclusion period. Death from natural causes inside the first two years returns the premiums paid rather than the $50,000. You are not covered for every condition from day one, and that does not make it a bad policy. It means you need to know exactly what you are covered for.
The rating does not follow you forever either. Once findings have been investigated, properly treated, and results come back within normal limits, we can apply for a change in rating. That is a real process with a real timeline, and it is worth running on any file that crosses a new stability threshold. For how premiums move across ages, terms and product types generally, see how much life insurance costs in Canada.
How to Apply After a Brain Tumour Diagnosis
The most important step happens before any formal application is submitted: the preliminary assessment. This is an anonymous inquiry to the underwriting desk at one or more carriers, sharing the medical specifics with no name attached. Underwriters reply with an indicative decision (likely rating, likely postpone, or likely decline) on those facts. No formal application has been filed, so no mark on the survivor’s record.
Skipping this step is the single most common way brain tumour files get harder than they needed to be. A formal application that comes back postponed or declined leaves a Medical Information Bureau record that the next carrier sees. The preliminary assessment exists specifically to avoid that outcome.
The working sequence on a typical file
Intake. Gather the documentation list from the previous section. Understand the coverage need (amount, term, type). Confirm the survivor’s current health picture.
Carrier shortlist. Match the file to current underwriting guides. Narrow to two or three carriers most likely to issue on these facts.
Anonymous preliminary assessment. Email or call the underwriting desk with the medical specifics. No name, no formal application. Indicative decision back within 3 to 10 business days at most carriers.
Run simplified-issue in parallel. If the fully underwritten preliminary looks tight, line up the simplified-issue alternative at the same time. Application questions and tier limits tell us whether the file qualifies before any submission.
Submit the formal application. One carrier only, based on the preliminary assessment result. Pathology report, treatment summary, and recent imaging go with the application.
Underwriting decision. Fully underwritten files: 4 to 8 weeks typically. Simplified-issue: 48 hours to 2 weeks. Guaranteed-issue: days.
Annual review for re-placement. As the survivor crosses additional time thresholds, better terms may open up at other carriers. The original policy stays in force until any new one issues. The transition is never broken.
The 4-to-8-week underwriting timeline applies to fully underwritten files. If coverage is needed quickly (mortgage closing, business transaction, child custody arrangement), simplified-issue or guaranteed-issue is the bridge, and fully underwritten coverage can be added later when timing allows.
One pattern worth flagging on brain tumour files specifically: many cases benefit from a two-product structure. A guaranteed-issue or simplified-issue policy goes in force immediately to lock in insurability, and a fully underwritten policy gets added two to five years later once the stability window opens. The first policy stays active until the second one issues. The survivor is never without coverage during the transition.
A formal decline at one carrier does not mean declined everywhere. Different Canadian carriers read the same brain tumour file very differently. A postpone at one is not a postpone at all of them. The preliminary assessment step is what surfaces this variation before any formal mark hits the survivor’s file.
Frequently Asked Questions
Question 1
Can I get life insurance if I have an untreated brain tumour being monitored?
Yes, in many cases. Small benign tumours found incidentally and under active surveillance (no surgery, no symptoms) can route to fully underwritten coverage at some Canadian carriers, particularly for findings under threshold size with stable imaging history. Others may rate the file or postpone until a stability window has passed. The preliminary assessment step is what surfaces which carrier reads the file which way. Guaranteed-issue may be available as a baseline option regardless of treatment status, subject to age, amount limits, product rules, and waiting-period conditions.
Question 2
Will a brain tumour show up on the Medical Information Bureau record?
Only if a formal life insurance, critical illness, or disability application has been submitted to a Canadian carrier and the carrier reported the file to MIB. The diagnosis itself does not appear on MIB. What appears is the underwriting outcome of any formal application that mentioned the diagnosis. This is why preliminary assessments matter. They allow underwriting input without leaving an MIB footprint.
Question 3
If I have an existing life insurance policy and get diagnosed with a brain tumour, does anything change?
Nothing changes. A policy issued before the diagnosis remains in force at the original premium with the original death benefit. The insurer cannot cancel the policy, exclude brain-related causes of death, or raise the premium because the insured was diagnosed during the policy. As long as the original application was complete and honest, a future brain-tumour-related death is paid out the same as any other cause of death. This is the most important reason to put coverage in place before any investigation or scan is on the file.
Question 4
Does the WHO grade of my tumour matter more than the type?
Both matter, and underwriters read both. WHO grade signals how aggressively the tumour behaves. Histological type signals which carrier guidelines apply (different tumour types have different stability windows and rating structures). A Grade 1 meningioma and a Grade 1 pilocytic astrocytoma are both benign but route somewhat differently across carriers. The pathology report carries both pieces of information, which is why it sits at the top of the documentation list.
Question 5
Do insurers care if my brain tumour is a primary tumour or a metastasis from another cancer?
Yes, substantially. A primary brain tumour is underwritten on its own. A metastatic brain tumour is essentially two cancers: the brain involvement and the original primary cancer (breast, lung, colon, melanoma). Routing depends on both. Metastatic files usually route to guaranteed-issue first, with simplified-issue and fully underwritten options opening up only after multiple years of stable remission across both cancers.
Question 6
Will residual neurological symptoms after treatment affect my application?
It depends on the severity and the carrier. Mild residual deficits (some hearing loss, mild balance issues, well-controlled post-treatment seizures on stable medication) are generally not application-breaking but may move the rating. More significant deficits (poorly controlled seizures, major cognitive impairment, ongoing functional limitations) tighten the carrier shortlist and may push routing toward simplified-issue or guaranteed-issue. Active seizure history may also affect driving license status independently.
Question 7
Is critical illness coverage worth getting after a brain tumour diagnosis?
Critical illness coverage on the specific brain tumour itself is generally excluded or postponed after a diagnosis at most Canadian carriers. However, critical illness coverage can still be issued for other covered conditions (heart attack, stroke, cancers of other organs, kidney failure, and others). A brain tumour survivor with a clean cardiac and metabolic picture may still benefit from CI coverage on the other listed conditions. The brain tumour itself becomes a no-pay condition on a new CI policy, but the other covered conditions remain in scope.
Question 8
How long after a benign tumour removal can I expect to qualify for standard rates?
For a Grade 1 benign tumour (meningioma, pilocytic astrocytoma, pituitary adenoma) that was fully removed with clean follow-up imaging, standard rates are realistic at multiple Canadian carriers somewhere between 2 and 5 years post-surgery. Some carriers move faster than others. Files with no residual neurological deficits, clean annual MRIs, and no other major medical history have the strongest chance of standard rates in the shorter end of that window. Older files with a longer stability history (5 to 10 years) may be able to reach standard rates if other risk factors are absent.
How we approach the file
At Protect Your Wealth, every brain tumour file gets worked the same way regardless of grade or timeline: pathology read first, anonymous preliminary assessment to the carriers that fit the facts, formal application only to the carrier with the best probable offer.
We compare across major Canadian carriers to source no-medical life insurance, critical illness insurance, term life, and permanent life insurance options for brain tumour survivors and patients. The goal on every file is coverage in force at the best terms the underwriting picture actually allows.
Talk to a broker directly
Or send a few details and we’ll respond the same business day.
Based in Hamilton, Ontario
Serving clients across Ontario, Alberta, British Columbia, Manitoba, Saskatchewan, New Brunswick, and Nova Scotia. Including Guelph, Toronto, Kamloops, and Medicine Hat.
